Breast Cancer Treatment in Raipur

Breast cancer is the most common cancer in women worldwide and the leading female malignancy in India, where incidence has risen sharply over the past two decades. The disease spans a wide spectrum, from non-invasive ductal carcinoma in situ to aggressive triple-negative subtypes that directly shape the treatment approach. Ramkrishna CARE Hospitals Raipur offers comprehensive breast cancer care through a dedicated multidisciplinary oncology unit equipped to manage the full range of breast cancers.

What Is Breast Cancer?

Breast cancer develops when ductal or lobular epithelial cells acquire mutations & start dividing uncontrollably. Each tumour carries a distinct molecular profile, including ER/PR-positive luminal tumours, HER2-positive tumours and triple-negative breast cancer (TNBC) managed with chemotherapy, immunotherapy and PARP inhibitors.

Types of Breast Cancer

Breast cancer is classified by cell of origin, invasion extent, and molecular subtype. Common types are:

• Ductal carcinoma in situ (DCIS): A non-invasive cancer confined entirely within the milk ducts. When detected and treated early, the prognosis is excellent.
• Invasive ductal carcinoma (IDC): The most common form of breast cancer. It begins in the milk ducts and grows into the surrounding breast tissue and further organs if not treated.
• Invasive lobular carcinoma (ILC): Originates in the milk-producing lobules rather than the ducts. Compared to other types, it is more likely to affect both breasts and can sometimes be harder to detect on standard imaging.
• HER2-positive breast cancer: Defined by an overexpression of the HER2 protein, this type tends to grow more rapidly.
• Hormone receptor-positive breast cancer: Cancer cells in this group carry receptors for oestrogen, progesterone, or both.
• Triple negative breast cancer (TNBC): This subtype lacks oestrogen, progesterone and HER2 receptors, which means hormone therapies and HER2 targeted drugs are not effective against it. It is more aggressive and seen more frequently in younger women & those carrying inherited BRCA mutations.
• Inflammatory breast cancer (IBC): A rare but aggressive form that presents with erythema and peau d'orange.
• Paget's disease of the breast: A rare cancer that affects the skin of the nipple and areola.

Symptoms of Breast Cancer

Many early breast cancers are detected on screening before symptoms arise. A painless lump is the most common presenting symptom, and other breast cancer symptoms are 

• Skin dimpling
• Nipple retraction
• Blood-stained nipple discharge
• Erythema and "peau d'orange" appearance 
• Firm axillary nodes
• Bone pain, breathlessness, and right upper quadrant discomfort suggest metastatic disease.

Breast Cancer Causes 

Breast cancer results from somatic and germline mutations in breast epithelial cells driven by hormonal and environmental factors. Prolonged oestrogen exposure including early menarche, late menopause, or nulliparity and BRCA1/2 germline mutations, are the primary factors. Long-term use of combined hormone therapy after menopause may increase breast cancer risk. Obesity, alcohol, and chest radiotherapy before age 30 are additional risk factors.

Stages of Breast Cancer

Breast cancer is staged using the eighth edition AJCC TNM system, incorporating tumour size, nodal status, grade and receptor status. Stages are

• Stage 0 (DCIS): Non-invasive cancer confined to the milk ducts 
• Stage I: Early-stage invasive breast cancer that is small and confined to the breast, with little or no lymph node involvement. 
• Stage II: The tumour is larger and/or has spread to a small number of nearby lymph nodes 
• Stage III: Locally advanced breast cancer that has spread extensively to nearby lymph nodes or surrounding tissues like the chest wall or skin but has not spread to distant organs 
• Stage IV: Advanced or metastatic breast cancer that has spread to distant parts of the body.

Diagnostic Tests for Breast Cancer

Diagnosis includes:

• Clinical assessment: The doctor checks for lumps, skin changes, nipple abnormalities and enlarged lymph nodes
• Digital mammography or tomosynthesis: The primary imaging test used to detect breast abnormalities 
• Breast Ultrasound: Helps distinguish between solid masses and fluid-filled cysts
• Breast MRI: Provides detailed images of the dense breast tissue or women under 40.
• Core needle biopsy: Provides tissue for histology and ER/PR/HER2 testing 
• PET-CT: Excludes distant metastasis
• Multigene profiling assays: Identify ER-positive, HER2-negative patients who can forego adjuvant chemotherapy.

Risk of Breast Cancer

Multiple clinical and biological factors elevate individual breast cancer risk:

• Female sex and advancing age (women aged 50 or above) are the strongest risk factors
• Prior DCIS or atypical hyperplasia increases the risk
• Dense breast tissue doubles risk
• Having a first-degree family history increases the risk two to threefold.

Complications of Breast Cancer

Advanced breast cancer produces significant complications requiring specialist supportive management. They are:

• Arm lymphoedema 
• Skeletal metastases cause bone pain, fractures, and spinal cord compression 
• Brain metastases.

Treatment for Breast Cancer

Breast cancer treatment is multimodal, sequenced by tumour subtype, stage, and fitness through multidisciplinary tumour team planning:

• Surgery: Lumpectomy removes the tumour with clear margins; mastectomy is used when tumour extent precludes conservation; sentinel lymph node biopsy avoids full axillary dissection in node-negative disease, reducing lymphoedema risk.
• Advanced treatments: Neoadjuvant chemotherapy, HER2-targeted agents, or endocrine therapy downstage locally advanced tumours and enable breast conservation.
• Radiotherapy: Adjuvant radiotherapy after lumpectomy reduces local recurrence by a lot. Post-mastectomy radiotherapy is indicated with four or more positive nodes or a tumour exceeding five centimetres.
• Hormone Therapy: Used for hormone receptor-positive breast cancers to block the effects of oestrogen and reduce cancer growth.
• Targeted Therapy: HER2 positive breast cancers benefit from targeted drugs that specifically attack HER2-positive cancer cells while sparing healthy tissues.
• Immunotherapy: Patients with triple-negative breast cancer benefit from immunotherapy.  

Prevention of Breast Cancer

No single intervention eliminates breast cancer risk but evidence-based strategies substantially reduce incidence:

• Aerobic exercise of at least 150 minutes weekly and limiting alcohol consumption reduce breast cancer incidence and recurrence risk.
• Breastfeeding for 12 or more months reduces risk 
• Chemoprevention with medicine reduces the incidence in high-risk women.
• Bilateral risk-reducing mastectomy reduces risk in BRCA1/2 carriers. 
• Annual mammography from age 40 (from age 25 in BRCA carriers) with supplemental MRI enables earlier detection.

Why Choose Ramkrishna CARE Hospitals for Breast Cancer Treatment in Raipur

Ramkrishna CARE Hospitals, Raipur, operates a breast oncology service with weekly multidisciplinary tumour team reviews. Digital mammography, tomosynthesis, breast ultrasound, and contrast-enhanced MRI are available in our hospital; same-day IHC, HER2 FISH, multigene profiling, and BRCA germline testing are performed in-house.

Breast-conserving surgery with oncoplastic techniques, nipple-sparing mastectomy, and immediate reconstruction are offered alongside sentinel node mapping. Chemotherapy, targeted therapy and immunotherapy are delivered in a day-care unit with a pharmacist. monitoring; hypofractionated and standard IMRT with daily image guidance is available. Patients across Chhattisgarh access this spectrum of care locally.